Floatz logo

RETINOL

Biliary Atresia

Children's Hospital of Fudan UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Biliary Atresia cohort.

Asset / SponsorPhaseRating
Pentoxifylline
Baylor College of Medicine
Phase 2CCC
Autologous Bone Marrow Mononuclear Cell Intra-Arterial
Vinmec Research Institute of Stem Cell and Gene Technology
Phase 1CC
Vancomycin
Sacramento Pediatric Gastroenterology
Phase 1CC
VITAMIN D
Children's Hospital of Fudan University
N/AD
Sulperazon
Children's Hospital of Fudan University
N/AD

View all 17 →

Same molecule, other indications

RETINOL is also rated in:

relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
65 / 100
View asset →
tuberculosisDormant
BB
Indicative ·
64 / 100
View asset →
HIV infectious diseaseDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →